Pfizer Revenue Beats Estimates

U.S. drugmaker Pfizer Inc, which is in the process of buying Botox-maker Allergan Plc for $160 billion, forecast 2016 revenue and earnings below analysts' estimates, citing generic competition and a strong dollar.